# Amphastar Pharmaceuticals, Inc. – FDA Inspection, Apr 3, 2025

Source: https://www.keypedia.com/records/fda_inspections/amphastar-pharmaceuticals-inc/f3a88961-407c-4d84-af4c-f19faea69e77
Source feed: FDA_Inspections

> FDA inspection 1266798 of Amphastar Pharmaceuticals, Inc., April 03, 2025. Classification: No Action Indicated (NAI). 14 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266798
- Company Name: Amphastar Pharmaceuticals, Inc.
- Inspection Date: 2025-04-03
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1290538 - 2025-11-07](https://www.keypedia.com/records/fda_inspections/amphastar-pharmaceuticals-inc/84de8825-ab9e-4fa3-a9c3-56d089df0daa)
- FDA Inspection 1229403 - 2024-03-01
- FDA Inspection 1144508 - 2021-06-22
- FDA Inspection 1113865 - 2019-11-22
- FDA Inspection 1115634 - 2019-11-21

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/samson-o-oluseye/bfe102f5-25cb-4ed9-9e69-2ec5ec0a047f)

Company: https://www.keypedia.com/companies/amphastar-pharmaceuticals-inc/e90eb882-5679-4c85-bbc8-f69ca69cc537

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c